Hepatitis C Drugs Boost Remdesivir’s Antiviral Activity Against COVID-19

Media Type
Article
Publish or Event Date
Research Institution
The University of Texas at Austin
Short Title
Hepatitis C Drugs Boost Remdesivir’s Antiviral Activity Against COVID-19
Content Coordinator
Content Manager